Γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Sharma, Anu ^a   Bode, Beata ^a   Wenger, Roland H ^b   Lehmann, Kuno ^a   Sartori, Alessandro A ^b   Moch, Holger ^a   Knuth, Alexander ^a   von Boehmer, Lotta ^a   van den Broek, Maries ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER TESTIS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER RADIOTHERAPY; CD8+ T LYMPHOCYTE; CELL HYPOXIA; CELL STRESS; CONTROLLED STUDY; EX VIVO STUDY; GAMMA RADIATION; GENOTOXICITY; HUMAN; HUMAN CELL; HYPERTHERMIA; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LYMPHOCYTIC INFILTRATION; MELANOMA CELL; OSTEOSARCOMA CELL; PROSTATE CANCER; RADIATION DOSE; TUMOR BIOPSY; TUMOR IMMUNITY; UPREGULATION;

ANTIGENS, NEOPLASM; BIOPSY; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; FEMALE; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 82255195940     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028217     Document Type: Article

References (38)

1. Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, et al. (2006) Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203: 1259-1271.
2. Mairs RJ, Fullerton NE, Zalutsky MR, Boyd M, (2007) Targeted radiotherapy: microgray doses and the bystander effect. Dose Response 5: 204-213.
3. Prise KM, O'Sullivan JM, (2009) Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 9: 351-360.
4. North RJ, (1984) Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells. Cancer Immunol Immunother 16: 175-181.
5. Matsumura S, Wang B, Kawashima N, Braunstein S, Badura M, et al. (2008) Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol 181: 3099-3107.
6. Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, et al. (2005) Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol 174: 7516-7523.
7. Pandey R, Shankar BS, Sharma D, Sainis KB, (2005) Low dose radiation induced immunomodulation: effect on macrophages and CD8+ T cells. Int J Radiat Biol 81: 801-812.
8. Lee Y, Auh SL, Wang Y, Burnette B, Meng Y, et al. (2009) Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 114: 589-595.
9. Schulz TF, (2009) Cancer and viral infections in immunocompromised individuals. Int J Cancer 125: 1755-1763.
10. Penn I, (1988) Tumors of the immunocompromised patient. Annu Rev Med 39: 63-73.
11. Karanikas V, Germenis A, (2009) Tumor specific CD8+ T cells in patients with lung cancer and healthy individuals. J BUON 14 (Suppl 1): S153-157.
12. Byers VS, Levin AS, Hackett AJ, Fudenberg HH, (1975) Tumor-specific cell-mediated immunity in household contacts of cancer patients. J Clin Invest 55: 500-513.
13. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, et al. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964.
14. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, et al. (2007) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. J Immunol 178: 2617-2621.
15. Gehring AJ, Ho ZZ, Tan AT, Aung MO, Lee KH, et al. (2009) Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 137: 682-690.
16. Parmigiani RB, Bettoni F, Vibranovski MD, Lopes MH, Martins WK, et al. (2006) Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients. Proc Natl Acad Sci U S A 103: 18066-18071.
17. Scanlan MJ, Simpson AJ, Old LJ, (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4: 1.
18. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT, (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188: 22-32.
19. Horig H, Medina FA, Conkright WA, Kaufman HL, (2000) Strategies for cancer therapy using carcinoembryonic antigen vaccines. Expert Rev Mol Med 2: 1-24.
20. Suri A, (2006) Cancer testis antigens-their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther 6: 379-389.
21. Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, et al. (2007) The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 17: 1140-1145.
22. Stewart-Jones G, Wadle A, Hombach A, Shenderov E, Held G, et al. (2009) Rational development of high-affinity T-cell receptor-like antibodies. Proc Natl Acad Sci U S A 106: 5784-5788.
23. Maria S, et al. (2005) Ex vivo analysis of T-cell function. Current Opinion in Immunology 17' 4: 434-440.
24. Valerie Rubio, Naileshni S, Michael R, Jeffrey W, Mario R, al et, (2003) Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 9: 1377-1382.
25. Jang ER, Choi JD, Park MA, Jeong G, Cho H, et al. (2010) ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response. Exp Mol Med 42: 195-204.
26. Park SK, Dadak AM, Haase VH, Fontana L, Giaccia AJ, et al. (2003) Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Mol Cell Biol 23: 4959-4971.
27. van den Beucken T, Koritzinsky M, Niessen H, Dubois L, Savelkouls K, et al. (2009) Hypoxia-induced expression of carbonic anhydrase 9 is dependent on the unfolded protein response. J Biol Chem 284: 24204-24212.
28. Kastan MB, Lim DS, (2000) The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1: 179-186.
29. Huen MS, Chen J, (2008) The DNA damage response pathways: at the crossroad of protein modifications. Cell Res 18: 8-16.
30. Pandita TK, Lieberman HB, Lim DS, Dhar S, Zheng W, et al. (2000) Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene 19: 1386-1391.
31. Demaria S, Bhardwaj N, McBride WH, Formenti SC, (2005) Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys 63: 655-666.
32. Hauser SH, Calorini L, Wazer DE, Gattoni-Celli S, (1993) Radiation-enhanced expression of major histocompatibility complex class I antigen H-2Db in B16 melanoma cells. Cancer Res 53: 1952-1955.
33. Chiriva-Internati M, Grizzi F, Pinkston J, Morrow KJ, D'Cunha N, et al. (2006) Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors. In Vitro Cell Dev Biol Anim 42: 89-95.
34. Shiao SL, Coussens LM, (2010) The tumor-immune microenvironment and response to radiation therapy. J Mammary Gland Biol Neoplasia 15: 411-421.
35. Gotter J, Brors B, Hergenhahn M, Kyewski B, (2004) Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J Exp Med 199: 155-166.
36. Charlie T Garnett CP, Mala Chakraborty, Kwong-Yok Tsang, Jeffrey Schlom, James W Hodge, (2004) Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Research 64: 7985-7994.
37. Wischnewski F, Pantel K, Schwarzenbach H, (2006) Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1,-A2,-A3, and-A12 in human cancer cells. Mol Cancer Res 4: 339-349.
38. Coral S, Sigalotti L, Altomonte M, Engelsberg A, Colizzi F, et al. (2002) 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications. Clin Cancer Res 8: 2690-2695.